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Varicella-zoster virus (VZV) open reading frame 8 (ORF8) is predicted to encode the viral dUTPase and the adjacent gene,
ORF9A, is thought to encode a membrane protein homologous to HSV-1 UL49.5. A fusion protein, in which the amino portion
of glutathione-S-transferase was fused to amino acids 5 to 396 of VZV ORF8 protein, had dUTPase activity in vitro. Construc-
tion of a mutant VZV with stop codons or a deletion in the ORF8 gene resulted in loss of viral dUTPase activity. Antibody
to VZV ORF9A protein demonstrated a 7-kDa protein located in the membranes of virus-infected cells. Insertion of stop
codons into VZV ORF9A resulted in VZV that produced smaller plaques than parental virus. Inactivation of both VZV ORF8
and ORF9A resulted in a virus that grew to lower titers and was impaired for syncytia formation when compared to parental
virus. In contrast, a similar mutation in HSV-1 has no effect on growth of the virus in vitro. These results identify loci in the
VZV genome that are required for a syncytial phenotype in vitro. q 1997 Academic Press
INTRODUCTION VZV ORF8 protein is homologous to the herpesvirus
dUTPases and contains five motifs conserved among
Varicella-zoster virus (VZV) causes chickenpox and these proteins (McGeoch, 1990). dUTPase catalyzes the
herpes zoster. Based on the sequence of the VZV ge- hydrolysis of dUTP to dUMP and pyrophosphate (Cara-
nome, Davison and Scott (1986) predicted that the virus donna and Cheng, 1981). dUTPase is present in mamma-
encoded 68 unique genes. Recent studies of HSV-1 have lian and prokaryotic organisms and is thought to have at
shown that it encodes several proteins in addition to least two critical roles in nucleic acid metabolism. First,
those predicted from the initial description of the se- by reducing levels of dUTP inside the cell, there is less
quence (McGeoch et al., 1988). These include UL26.5, likelihood of misincorporating uracil into nascent DNA.
US8.5, ICP34.5, ORF O, ORF P, and UL49.5 (Roizman and HSV-1 dUTPase mutants have a fivefold increase in their
Sears, 1996). mutation frequency relative to wild-type virus (Pyles and
HSV-1 UL49.5 encodes a 91 amino acid hydrophobic Thompson, 1994). Second, since dUMP is converted into
protein expressed late in the viral replicative cycle dTMP, dUTPase is important for the synthesis of dTMP.
(Barker and Roizman, 1992; Barnett et al., 1992). UL49.5 The herpesvirus dUTPases differ from the mammalian
protein is dispensable for HSV-1 replication in cell culture dUTPases. The herpesvirus enzymes are much larger in
(Pyles et al., 1992). Recently, Jons et al. (1996) showed size than their mammalian counterparts. In addition,
that pseudorabies virus UL49.5 encodes an O-glycosyl- while the order of the five conserved motifs within the
ated protein present in the envelope of the virus. In addi- protein are identical for the herpesvirus dUTPases, the
tion, bovine herpesvirus 1 was shown to contain a virion arrangement of these motifs is different for the mamma-
protein, UL49.5, that forms a complex with a second vi- lian enzymes.
rion protein (Liang et al., 1996). VZV encodes a homolog We have confirmed that VZV ORF8 encodes the viral
of UL49.5, designated ORF9A (McGeoch et al., 1993), that dUTPase by demonstrating that a fusion protein con-
has an equivalent position in the genome and is pre- taining ORF8 protein has dUTPase activity in vitro. Dele-
dicted to encode a protein with a secondary structure tion of ORF8 results in loss of VZV dUTPase activity and
similar to that of HSV-1 UL49.5 protein. VZV ORF9A pro- is not essential for virus replication in the cell. Further-
tein is predicted to be 87 amino acids in length with an more, the adjacent ORF9A gene encodes a 7-kDa protein,
amino terminus that overlaps with the first nine amino present in the membranes of infected cells, that is also
acids of the VZV ORF8 protein. dispensable for replication. Finally, we show that inacti-
vation of both ORF8 and ORF9A results in a virus that
grows to lower titers than parental virus in cell culture1 To whom reprint requests should be addressed at Bldg. 10, Rm.
11N214, NIH, Bethesda, MD 20892. Fax: (301) 496-7383. and is impaired for formation of syncytia in vitro.
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MATERIALS AND METHODS dent clones of plasmid pEcoN9AS were used to produce
mutant VZV.
Cells and virus Plasmids pEcoN8S, pEcoN9AS, and pEcoN8D con-
taining stop codons in ORF8 or ORF9A, or a deletion inMeWo cells, a kind gift from Dr. Charles Grose, are
ORF8, respectively, were transformed into Escherichiaderived from a human melanoma and were maintained in
coli strain GM2150 which lacks the dam methylase. Plas-minimum essential Eagles’s medium (Quality Biologicals,
mid DNA was isolated and digested with Bsu36I and Bcl IInc., Gaithersburg, MD) supplemented with 10% fetal bo-
which cut at VZV nucleotides 9,115 and 10,787, respec-vine serum. Recombinant VZV was propagated by inocu-
tively. The resulting fragments, containing the ORF8 orlation of MeWo cells with virus-infected cells.
ORF9A mutations, were inserted into plasmid NS which
had also been grown in E. coli GM2150 and cut withCosmid DNAs
Bsu36I and Bcl I. The resulting plasmids were digested
with NotI and SstI and the fragments spanning VZV nucle-Four cosmids containing overlapping VZV DNA frag-
ments from the Oka strain (Cohen and Seidel, 1993) were otides 1 to 11,437 were inserted into the VZV NotIA cos-
mid in place of the wild-type VZV DNA sequence. Cos-used for MeWo cell transfections (Fig. 1). The putative
VZV dUTPase is encoded by VZV ORF8, with a start co- mids VZV NotIA-8S, NotIA-9AS, and NotIA-8D contain the
VZV ORF8 gene with a stop codon after the 56th codondon at VZV nucleotide 10,667 and a stop codon at nucleo-
tide 9,480 (Davison and Scott, 1986). To produce a cos- of ORF8, the ORF9A gene with a stop codon after the
9th codon of ORF9A, and the ORF8 gene with a deletionmid with a large deletion or a stop codon in ORF8, plas-
mid NS containing VZV nucleotides 1 to 11,437 cloned of codons 58 to 366, respectively (Fig. 1).
into the NotI– SacI site of pBluescript II KS/ (Strategene,
La Jolla, CA) was digested with EcoNI, which cuts at Transfections
VZV nucleotides 8,721 and 10,919. The 2.2-kb VZV DNA
fragment was ligated into an EcoNI restriction site which Cosmids were linearized by digestion with NotI or
Bsu36I and transfection mixtures contained 1 mg of cos-had been inserted into plasmid pNEB 193 (New England
Biolabs, Beverly, MA), resulting in plasmid pEcoN2.2. To mid MstIIA, 1.5 mg each of cosmid MstIIB, NotIBD, and
the mutant NotIA cosmid, along with 2 mg of shearedcreate a plasmid with a stop codon in ORF8, plasmid
pEcoN2.2 was digested with AccI which cuts at VZV nu- salmon sperm DNA, and 50 ng of plasmid pCMV62.
Transfection of MeWo cells was performed as previouslycleotide 10,500 and the ends were blunted using the
Klenow fragment of E. coli DNA polymerase I. A 20-base described (Cohen and Seidel, 1993).
pair double-stranded oligonucleotide (TAGCTAGGC-
GCGCCTAGCTA) that contains an AscI restriction site Southern and Northern blots
and stop codons in all three reading frames was inserted
into the AccI site of pEcoN2.2, resulting in plasmid VZV DNA was purified from nucleocapsids, cut with
EcoRI, BamHI, or EcoRI and AscI, fractionated on aga-EcoN8S. To create a plasmid with a deletion within ORF8,
plasmid pEcoN2.2 was digested with Bgl II and AccI rose gels, and transferred to nylon membranes. The four
parental DNA cosmids, spanning the entire VZV genome,which cut at nucleotides 9,565 and 10,500. The ends of
the plasmid were blunted using the Klenow fragment were radiolabeled with [32P]dCTP and hybridized to the
immobilized VZV DNA. A 2.2-kb EcoNI fragment, con-of DNA polymerase I and were ligated to themselves
resulting in plasmid pEcoN8D, which has a 935-base taining VZV nucleotides 8,721 to 10,919, which includes
both ORF8 and ORF9A, was radiolabeled to demonstratepair deletion in VZV ORF8. Each of the mutated plasmids
was sequenced to confirm the presence of the inserted specific mutations.
For Northern blots, total RNA was isolated from VZV-oligonucleotide or the expected deletion. Two indepen-
dent clones of each plasmid pEcoN8S and pEcoN8D infected MeWo cell cultures using the acid guanidine
thiocyanate-phenol-chloroform extraction procedurewere used to produce two independent mutant viruses.
VZV ORF9A protein is encoded by VZV nucleotides (Chomczynski and Sacchi, 1987), fractionated on a 1%
agarose/2% formaldehyde gel, and transferred to a nylon10,642 to 10,902. To produce a cosmid with stop codons
in ORF9A, plasmid pEcoN2.2 was partially digested with membrane. A single-stranded probe complementary to
VZV ORF9 (VZV nucleotides 11,251 to 11,005) was pre-AseI. AseI cuts at VZV nucleotide 10,669 as well as two
other sites in the pNEB 193 vector. Single-cut plasmid pared by linearizing plasmid pEcoN2.2 with SnaBI and
using PCR with oligonucleotide GGAGTCGTTTGGTTG-was isolated by gel purification, the ends were blunted
using the Klenow fragment of DNA polymerase I, and ATGTAC, Taq DNA polymerase, and [32P]dCTP. A probe
complementary to VZV ORF9A (VZV nucleotides 10,902the 20-base pair oligonucleotide containing stop codons
(described above) was inserted. Plasmids in which the to 10,669) was prepared by linearizing plasmid pEcoN2.2
with AseI and using PCR with oligonucleotide CCACGT-oligonucleotide was inserted into the ORF9A gene were
selected and confirmed by sequencing. Two indepen- GCTGCGTAATACAG (Bednarczuk et al., 1991).
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FIG. 1. Construction of recombinant VZV with stop codons in ORF8 or ORF9A, or a deletion in ORF8. The prototype VZV genome is 124,884 bp in
length (line 1) and consists of unique long (UL), unique short (US), terminal repeat (TR), and internal repeat (IR) DNA sequences (line 2). A BamHI restriction
map is shown (line 3). NotI (line 4) and MstII (line 5) restriction fragments are used to generate recombinant VZV. The nucleotide positions are based
on the prototype genome (Davison and Scott, 1986) and the 3* end of cosmid NotI A (indicated in parentheses) terminates within the R3 repeat region
before the NotI site. Cosmid VZV NotIA-8S (line 6) has stop codons inserted after the 56th codon of ORF8. Cosmid NotIA-8D has a deletion in ORF8
resulting in loss of codons 58 to 366 (line 7). Cosmid NotIA-9AS (line 8) has stop codons inserted after the 9th codon of ORF9A. Restriction sites used
in cloning the mutants (line 9) and a map of the VZV open reading frames in the region of ORF8 and ORF9A (lines 10, 11) are shown.
Growth characteristics of recombinant VZV plaques for each VZV mutant was determined. The Tukey
multiple comparison test was used to determine the sta-Growth curves were generated by infecting MeWo
tistical significance of the differences.cells with cells containing about 200 PFU of VZV. At Days
1, 2, 3, 4, and 5 after infection, the cells were harvested, dUTPase assays
and serial dilutions were used to inoculate uninfected
MeWo cells. Plaques were stained and counted 7 days Infected or uninfected MeWo cells were scraped from
flasks, washed in phosphate-buffered saline, pelleted,after infection.
The diameter of stained plaques was measured using resuspended in 1 ml of extraction buffer (10 mM Tris–
HCl, pH 8.0, 1 mM MgCl2 , 20% (vol/vol) glycerol), andan inverted microscope and the mean plaque size of 20
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lysed by ultrasonic disruption (Branson Sonifier Model contained a SmaI site followed by VZV nucleotides 10,653
to 10,628 (CGTCCCGGGAATTGATCCCATCTTGGAAAC-350; microprobe power setting 5 for four 15-sec bursts).
The sonicate was centrifuged and the supernatant was GGCAG), and the second primer contained an EcoRI site
followed by VZV nucleotides 5,477 to 5,500 (CGAATTCTT-used for determining dUTPase activity using nondenatur-
ing polyacrylamide gel electrophoresis (PAGE) and the AATGTTTTAGTAGAAAATCGAC). The amplified DNA was
digested with EcoRI and SmaI and inserted into plasmidstandard DE81 disc assay (Williams and Parris, 1987).
Nondenaturing PAGE was performed on 5% gels. Su- pGEX-2T (Pharmacia, Piscataway, NJ), which contains a
portion of the glutathione-S-transferase (GST) gene. Twopernatants containing equal amounts of protein were ap-
plied to the gels and electrophoresis was performed at 47 independent clones, pGEX-2TVZV-ORF8.1 and 8.2, were
obtained. The plasmids were grown in E. coli strain CJ236at 200 V for 3 hr. Protein concentration was determined by
Coomassie blue dye binding assay (Bio-Rad Laboratories, (dut0, ung0). To induce GST–dUTPase fusion protein,
bacteria were inoculated into 2XYT medium with 2% glu-Hercules, CA). Following electrophoresis, gels were then
removed from the tube and cut into 3-mm sections. Each cose and ampicillin, grown to an A600 of 0.4, and IPTG
was added. The bacteria were lysed and dUTPase activ-section was assayed in 150 ml of dUTPase reaction mix-
ture (50 mM Tris–HCl, pH 8.0, 1 mM MgCl2 , 0.1 mM [5- ity was determined. GST–dUTPase fusion protein was
purified with glutathione–Sepharose, washed exten-3H]dUTP (50 mCi/umol), 2 mM b-mercaptoethanol, 0.1%
(w/v) bovine serum albumin, 2 mM p-nitrophenyl phos- sively, and eluted with reduced glutathione. Human (Cli-
mie et al., 1994) and yeast (McIntosh et al., 1994)phate, 5 mM ATP) for 17 or 21 hr at 377. Reactions were
terminated by spotting 50 ml of the mixture onto a DE81 dUTPase fusions proteins were kind gifts from Dr. Evan
McIntosh. HSV-2 dUTPase fusion protein was con-filter disc and immediately washing the disc twice in 4 M
formic acid and 1 mM ammonium formate. Discs were structed by cutting plasmid pGEMsdUT3 (a gift of Dr. Sal
Caradonna) with EcoRI to release a 1.3-kb DNA fragmentwashed in ethanol, dried, and the amount of radioactivity
bound to the disc was determined. One unit of dUTPase containing the HSV-2 strain 333 dUTPase gene with adja-
cent EcoRI linkers. The 1.3-kb fragment was inserted intoactivity was defined as the amount of enzyme that hy-
drolyzed 1 nmol of dUTP/min/ml at 377 (Williams and Paris, the EcoRI site of pGEX-3X to generate pGEX-3XHSV-2dut
(Becher and Williams, unpublished observations).1987). An extract from E. coli CJ236 containing a pGEX–
HSV-2 dUTPase fusion protein (see below) served as a
positive control; the same extract that had been heat inac- RESULTS
tivated served as a negative control. For a given cell lysate,
VZV ORF8 is not required for growth of the virus in
dUTPase activity varied by £10% in repeated assays.
cell culture
Antibodies, immunoblots, and cell fractionation Two cosmids, VZV NotIA-8SA and NotIA-8SB, were
studies constructed that contain a 20-base pair oligonucleotide
which results in stop codons after the 56th codon ofA synthetic peptide corresponding to amino acids 19
to 33 of VZV ORF9A protein (CEDSSGEPNFAERNF) was ORF8. Two other cosmids, VZV NotIA-8DA and NotIA-
8DB, have a deletion of 935 base pairs resulting in lossconjugated to malemide-activated keyhole limpet hemo-
cyanin (Pierce, Rockford, IL). Two rabbits were immu- of amino acids 58 to 366, followed by a frameshift, in the
ORF8 protein.nized three times with 2 mg of conjugated peptide and
antiserum was obtained. Antiserum was absorbed three MeWo cells were transfected in 60-mm dishes with
VZV cosmids NotIBD, MstIIA, MstIIB, and either parentaltimes with lysates of uninfected MeWo cells.
VZV-infected and uninfected cell lysates were boiled, or mutated cosmid NotIA. Five days after transfection,
the cells were treated with trypsin and seeded into 75-fractionated on SDS–polyacrylamide gels, and transferred
to a nylon membrane. The membrane was incubated for 1 cm2 flasks. Four days later (9 days after transfection)
cytopathic effects including syncytia formation andhr with rabbit antiserum to VZV ORF9A protein or murine
monoclonal antibody to VZV gE (Chemicon, Temecula, CA), rounded up cells were seen in cells transfected with the
four parental VZV cosmids or cells transfected with thewashed, incubated for 30 min with horseradish peroxidase
conjugated anti-rabbit or anti-mouse antibody, washed, and three parental cosmids and cosmid VZV NotIA-8SA. The
following day cells were again treated with trypsin anddeveloped using enhanced chemiluminescence (Amer-
sham Corp., Arlington Heights, IL). seeded into 175-cm2 flasks and 4 days later (14 days
after transfection) typical cytopathic effects were seen inMembrane and cytosolic fractions from VZV-infected
MeWo cells were prepared as previously described (Co- cells transfected with the three parental cosmids and
cosmid VZV NotIA-8SB. On the same day atypical cyto-hen and Seidel, 1995).
pathic changes, consisting of very small plaques without
Generation of dUTPase fusion protein syncytia, were seen in cells derived from the three paren-
tal cosmids and cosmid VZV NotIA-8DA or NotIA-8DB.The coding region of VZV ORF8, from codons 5 to 396,
was amplified by PCR using two primers. The first primer Two independent VZV ORF8 stop codon mutants,
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dUTPase activity was present in bacteria containing the
ORF8 fusion protein (pGEX-2TVZV-ORF8.1 or 8.2) and
peak levels occurred 2 hr after IPTG induction (Table 1).
No dUTPase activity was present in bacteria containing
the glutathione-S-transferase protein alone (pGEX-2T), in-
dicating that dUTPase activity was due to the VZV ORF8
protein. E. coli expressing fusion constructs containing
the HSV-2, yeast, or human dUTPase also showed
dUTPase activity.
Effect of a deletion in ORF8 on transcription of
adjacent genesFIG. 2. Southern blot of DNAs from recombinant VZV with stop co-
dons in ORF8 or ORF9A, or a deletion in ORF8. Virion DNAs were The 935-base pair deletion in ORF8 was constructed
digested with EcoRI (A), BamHI (B; C, lanes 1–3), or EcoRI and AscI
to create a VZV mutant that could not express functional(C, lanes 4–6; D). Hybridization with all four radiolabeled cosmid DNAs
viral dUTPase. Two genes, ORF9A and ORF9, couldshows similar patterns of restriction fragments (A, B). Hybridization with
an EcoNI fragment spanning ORF8 shows replacement of 8.4- and have promoters that lie within the region deleted in
2.3-kb fragments with a 9.8-kb fragment in ROka8D (C, lanes 1–3), ORF8 (Fig. 1, lines 10, 11). To determine whether this
replacement of a 14.3-kb fragment with fragments of 10.1 and 4.2 kb deletion affects transcription of adjacent genes, North-
in ROka8S (C, lanes 4–6), and replacement of a 14.3-kb fragment with
ern blots were performed using probes to ORF9A andfragments of 10.2 and 4.1 kb (not visible in the exposure shown) in
ROka9AS (D). Numbers indicate sizes of DNAs in kilobase pairs.
ROka8SA and ROka 8SB, and two ORF8 deletion mutants,
ROka8DA and ROka 8DB, were isolated.
Southern blot analysis confirmed that the recombinant
viruses contained the expected deletions or insertions.
EcoRI and BamHI restriction fragments of the recombi-
nant viral genomes did not show any unanticipated rear-
rangements (Figs. 2A and 2B). The deletion in ROka8D
DNA results in loss of the BamHI site at VZV nucleotide
10,147. Hybridization with a probe spanning ORF8
showed loss of two BamHI fragments (8.4 and 2.3 kb)
and a new fragment of 9.8 kb in ROka8D (Fig. 2C, lanes
1–3). Digestion of ROka8S with both EcoRI and AscI cut
the 14.3-kb EcoRI C band of VZV DNA into two bands of
10.1 and 4.2 kb due to the AscI site in the oligonucleotide
inserted into the genome at nucleotide 10,500 (Fig. 2C,
lanes 4–6).
VZV ORF8 encodes the viral dUTPase
Lysates from VZV-infected and uninfected MeWo cells
were fractionated on nondenaturing polyacrylamide tube
gels to separate cellular dUTPase from viral UTPase ac-
tivity. Cellular dUTPase activity was located in gel slices
at Rf values ranging from 0.3 to 0.7 in all lysates tested,
including uninfected MeWo cells. Viral dUTPase activity
was found in gel slices at Rf values from 0.04 to 0.2 in
lysates from cells infected with parental VZV ROka, but FIG. 3. dUTPase activity in cells infected with VZV mutants. Cell
not in cells infected with ORF8 deletion or stop codon lysates were electrophoresed on nondenaturing gels and gel slices
were assayed for dUTPase activity as described under Materials andmutants (Fig. 3).
Methods. In the first experiment dUTPase assays were performed usingTo verify directly that ORF8 encodes a dUTPase, a
uninfected cells (A), or cells infected with VZV ROka (B), ROka8D (C),fusion protein was constructed in which amino acids 5
or ROka8S (D). In the second experiment dUTPase assays were done
to 396 of ORF8 were fused to glutathione-S-transferase. using uninfected cells (E) or cells infected with VZV ROka (F), ROka8D
Extracts were prepared from bacteria containing the (G), or ROka9AS (H). Cells infected with each virus were assayed at
least twice.ORF8 fusion protein at various times after IPTG induction.
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TABLE 1
dUTPase Activity of E. coil Containing VZV ORF8 Fusion Protein
dUTPase Activity (U/mg protein) at time after induction
Plasmid 0 hr 1 hr 2 hr 4 hr 24 hr
None 0.001 0.001 0.001 0.001 0.001
pGEX-2T 0.001 0.001 0.001 0.001 0.001
pGEX-2TVZV-ORF8.1 0.001 10.9 52.9 11.1 6.00
pGEX-2TVZV-ORF8.2 0.001 8.44 21.3 8.23 6.81
pGEX-2THUM 26.8 246 209 NDa 185
pGEX-2TYeast 2.45 295 182 ND 198
pGEX-3X 0.001 0.001 0.001 0.001 0.001
pGEX-3XHSV-2dut 0.001 43.7 73.4 190 4.51
a ND, not done.
ORF9. The ORF9A probe identified a 1.7-kb transcript VZV ORF9A encodes a 7-kDa membrane protein in
VZV-infected cellsin cells infected with VZV ROka or ROka8S, but not in
cells infected with ROka8D (Fig. 4A). In contrast, an
VZV ORF9A is predicted to encode an 87 amino acidORF9 probe detected a prominent band of 1.2 kb in
protein that is highly hydrophobic based on a Kyte andcells infected with VZV ROka, ROka8S, or ROka8D, and
Doolittle hydropathic analysis (Barker and Roizman,a minor band of 1.7 kb in cells infected with VZV ROka
1992). The protein has a predicted molecular weight ofand ROka8S, but not ROka8D (Fig. 4B). These results
9.8 kDa; after the putative signal sequence is removedare consistent with 3*coterminal transcripts in which
the weight would be 7.2 kDa. Rabbit antiserum preparedthe 1.7-kb transcript encodes both ORF9A and ORF9,
against a peptide corresponding to amino acids 19 to 33while 1.2-kb transcript encodes ORF9 alone. Thus, the
of the predicted ORF9A protein recognized a protein ofdeletion in ORF8 removes a portion of the promoter for
7 kDa in a lysate of VZV ROka or ROka8S-infected cellsthe larger transcript and prevents transcription of the
on immunoblot (Fig. 5A). A similar protein was not pres-1.7 mRNA (encoding ORF9A and ORF9), but does not
ent in uninfected cells or cells infected with mutantsaffect transcription of the 1.2-kb transcript (encoding
containing a deletion in the putative ORF9A promoterORF9). In contrast, insertion of stop codons in ORF8
sequence (ROka8D) or a stop codon in ORF9A (see be-does not affect the promoter of the 1.7-kb transcript.
low). Immunoblot of another aliquot from the same pro-
tein extracts indicated that all of the VZV-infected cell
lysates used expressed VZV gE (Fig. 5B).
Immunoblot of membrane and cytosolic fractions from
VZV-infected MeWo cells showed that ORF9A protein
was present in the membrane fraction, but not the cyto-
solic fraction, of infected cells (Fig. 5C). Immunoblot of
another aliquot of the fractions indicated that VZV gE
was present only in the membrane fraction (Fig. 5D).
VZV ORF9A is not required for growth of the virus in
cell culture
Cosmid VZV NotI-9AS contains stop codons inserted
at VZV nucleotide 10,669 after the 9th codon of ORF9A.
MeWo cells were transfected with the three parental cos-
mids and cosmid NotIA-9S. Five days later the cells were
passaged and 4 days later cytopathic effects typical of
FIG. 4. Northern blots of transcripts from ORF9A and ORF9 in cells VZV infection were seen in cells derived from the four
infected with VZV ROka or ORF8 mutants. Hybridization with an ORF9A parental cosmids, while atypical cytopathic effects con-
probe shows a 1.7-kb transcript in cells infected with VZV ROka or the sisting of small plaques with reduced syncytia formation
ORF8 stop codon mutants (A). Hybridization with an ORF9 probe shows
were seen in cells transfected with the parental cosmidsa major band of 1.2 kb in cells infected with each of the viruses, and
and NotIA-9AS. Two independent VZV ORF9A mutants,a minor band of 1.7 kb in cells infected with VZV ROka or the ORF8
stop codon mutants (B). Numbers indicate sizes of RNAs in kilobases. ROka9ASA and ROka9ASB, were obtained.
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FIG. 5. Immunoblot of proteins from uninfected cells or cells infected with parental or ORF8 or ORF9A mutant VZV. Lysates from cells infected
with VZV ROka or ROka8S express a protein of 7 kDa that reacts with antibody to ORF9A; however, lysates from uninfected cells or cells infected
with the ROka9AS or ROka8D mutants do not contain the 7-kDa protein (A). Cells infected with VZV ROka, ROka8D, ROka9AS, or ROka8S express
proteins of 65–100 kDa that react with monoclonal antibody to VZV gE (B). ORF9A protein is located in the membrane of VZV-infected cells. Cytosolic
(lanes 1, 3) and membrane (lanes 2, 4) fractions were prepared from uninfected or VZV ROka-infected MeWo cells and immunoblotted with antibody
to ORF9A protein (C) or VZV gE (D). Additional bands (⁄34 kDa) in C are nonspecific, since they are also present in lysates from uninfected cells.
Numbers indicate molecular masses of proteins in kilodaltons.
Southern blot analysis of the viral DNAs showed no titers similar to those seen with the parental virus (Fig.
6A). Thus, the plaque size and titration experiments to-unexpected genomic rearrangements after digestion
with EcoRI or BamHI (Figs. 2A and 2B). Digestion of gether indicate that inability to express both VZV ORF8
and ORF9A impaired the growth of virus.ROka9AS DNA with EcoRI and AscI cut the 14.3-kb EcoRI
C fragment of VZV DNA into fragments of 10.2 and 4.1
Inability to express both VZV ORF9A and ORF8kb (not visible on this exposure) due to the AscI site in
proteins reduces syncytia formation in cell culturethe oligonucleotide that was inserted in ORF9A (Fig. 2D).
Viral dUTPase activity was found in cells infected with The plaque morphologies for cells infected with the
VZV ROka and VZV ROka9AS, indicating that insertion of three mutants were compared by infecting melanoma
a stop codon in ORF9A did not abolish dUTPase activity cells and growing the cells for 7 days. Cells infected
from ORF8 protein (Fig. 3). The level of viral dUTPase with VZV ROka8D were markedly impaired for syncytia
activity was slightly less for cells infected with VZV formation compared with cells infected with VZV ROka
ROka9AS than ROka. (Figs. 7A and 7D). Impaired syncytia formation was also
seen in Vero cells infected with VZV ROka8D (Ross and
Inability to express both VZV ORF9A and ORF8 Cohen, unpublished observations). Melanoma cells in-
proteins impairs the growth of virus in cell culture fected with VZV ROka9AS (Fig. 7C) showed a modest
reduction in formation of syncytia compared to ROka,The plaque size of cells infected with VZV ROka,
while cells infected with ROka8S (Fig. 7B) had a similarROka8S, ROka8D, and ROka9AS were compared by in-
fecting melanoma cells and staining the monolayers with
crystal violet 1 week after infection. Cells infected with TABLE 2
VZV ROka8D or ROka9AS produced smaller plaques (P
Plaque Sizes of VZV ORF8 and ORF9A Mutants0.01, Tukey multiple comparison test) than cells in-
fected with parental virus (Table 2). In contrast, cells Mean plaque size
infected with VZV ROka8S produced plaques that were (mm) { standard deviation (mm)
nearly the same size as cells infected with parental virus.
Virus Expt 1 Expt 2To determine if inactivation of VZV ORF8 or ORF9A
alters the growth of virus in cell culture, melanoma cells
ROka 0.61 { 0.14 0.50 { 0.09
were infected with VZV mutants or parental virus and the ROka8SA 0.48 { 0.16 ND
titer of virus was determined on Days 0 through 5 after ROka8SB 0.51 { 0.15 ND
ROka8DA 0.20 { 0.08 NDinfection. VZV ROka8DA and ROka8DB grew to lower
ROka8DB 0.19 { 0.08 NDtiters than the parental virus (Fig. 6A, B). VZV ROka9ASA
ROka9ASA ND 0.23 { 0.07and ROka9ASB grew to nearly the same levels as paren-
ROka9ASB ND 0.22 { 0.09
tal virus (Fig. 6B). VZV ROka8SA and ROka8SB grew to
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FIG. 6. Growth curves of VZV mutants in cell culture. Melanoma cells were inoculated with VZV-infected cells and 1 to 5 days later cells were
treated with trypsin, and the titer of virus was determined by plating on melanoma cells. Day 0 indicates the titer of the virus in the input inoculum.
VZV ROka and ORF8 mutants (A) and VZV ROka and ORF8 and ORF9A mutants (B) were assayed.
morphology to those infected with parental virus. Thus, cells. In addition, bacteria containing ORF8 expressed a
syncytia formation is markedly impaired when both ORF8 fusion protein that possesses dUTPase activity. E. coli
and ORF9A are not expressed. expressing the HSV-2, human, or yeast fusion proteins
had more dUTPase activity than the same bacteria ex-
DISCUSSION pressing the VZV fusion protein. While we are uncertain
as to why this occurred, it may reflect lower enzymaticWe have shown that a VZV mutant that cannot express
activity of the VZV protein, differences in the stability ofboth VZV ORF8 and ORF9A proteins is impaired for
the proteins in E. coli, minor differences in the constructsgrowth and syncytia formation in cell culture. In contrast,
(depending on the sites that the dUTPase sequences arelack of expression of VZV ORF8 alone had no effect on
fused to the foreign protein), or changes in the secondarygrowth and syncytia formation in vitro, while a mutation in
structure of the fusion proteins.ORF9A alone had a modest effect on syncytia formation.
The deletion in the ORF8 gene resulted in loss of aVZV ORF9A encodes a 7-kDa protein present in the
portion of the promoter for ORF9A and lack of expressionmembranes of infected cells. The predicted amino acid
of ORF9A protein. Analysis of transcription in this regionsequence of ORF9A protein contains a putative signal
using a single-stranded probe specific for ORF9 indi-sequence and transmembrane domain, but no predicted
cated two transcripts of 1.2 and 1.7 kb, while a probeN-linked glycosylation site. While the function of this pro-
specific for ORF9A showed a single band of 1.7 kb. Thistein is presently unknown, insertion of stop codons into
implies that ORF9A is translated from an mRNA (1.7 kb)the VZV gene resulted in a virus that produced smaller
that encodes both ORF9A and ORF9, while ORF9 can beplaques and showed a modest reduction in syncytia for-
translated from mRNAs of either 1.2 or 1.7 kb (Figs. 1mation in vitro. Other alphaherpesviruses, as well as hu-
and 4). Analysis of the corresponding region of HSV-1man cytomegalovirus and Epstein–Barr virus, have ho-
indicates a similar pattern of transcription (Hall et al.,mologs of ORF9A based on position in the genome and
1982; Pyles et al., 1992). HSV-1 UL49.5 (the homolog ofhydrophobicity profiles (McGeoch et al., 1993). HSV-1
VZV ORF9A) is translated from an mRNA that encodes(Barker and Roizman, 1992) has been shown to encode
both UL49.5 and UL49 (the homolog of VZV ORF9), whilea protein, designated UL49.5 or UL49A, that has a similar
UL49 can be translated from either of two overlappinghydrophobic profile as VZV ORF9A. Lack of HSV-1 UL49.5
transcripts. Analysis of the region upstream of VZVdoes not affect neurovirulence of HSV-1 (Pyles et al.,
ORF9A indicates a putative TATA element (TATAAAA)1992).
located 220 bp before the initiation codon.VZV ORF8 encodes the viral dUTPase. Nondenaturing
Inactivation of both ORF8 and ORF9A proteins resultedPAGE analysis of extracts from wild-type and VZV ORF8
in a virus that grew to lower titers than parental virus indeletion mutants demonstrated that mutants lacking
ORF8 are unable to produce viral dUTPase in infected cell culture. However, a similar deletion mutant in HSV-
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FIG. 7. Morphology of plaques in cells infected with VZV ORF8 and ORF9 mutants. Cells infected with VZV ROka (A) or ROka8S (B) show plaques
with large syncytia at the edges of the plaques. Cells infected with ROka9AS (C) have plaques with reduced syncytia, while cells infected with
ROka8D (D) have plaques with little or no syncytia.
1 which prevented expression of HSV-1 dUTPase and and Grose, 1995). Scanning electron microscopy shows
viral particles present in clusters overlying the syncytia.UL49.5 proteins replicated to a similar level as wild-type
virus (Pyles et al., 1992). A similar mutant, resulting in Virions are released from these infected cells only after
the cell membranes fuse to adjacent cells (Rodriguezdeletion of the entire ORF9A homolog and the amino
terminus of the dUTPase of bovine herpesvirus 1, was et al., 1993). Polykaryocytosis is due to viral fusogens
(Roizman, 1962). VZV gH is a fusogen and monoclonalalso constructed; however, the growth properties of this
mutant were not described (Liang et al., 1993). A antibody to VZV gH blocks formation of syncytia and
transmission of virus from infected to uninfected cellsdUTPase mutant of pseudorabies virus, which leaves the
ORF9A homolog intact, grew to similar final titers as (Keller et al., 1987; Rodriguez et al., 1993). In contrast,
monoclonal antibodies to VZV ORF62, gB, gE, or gI dothose seen with wild-type virus (Jons and Mettenleiter,
1996). not alter formation of syncytia. While VZV variants that
result in large syncytia have been reported (Nii andVZV unable to express both ORF8 and ORF9A proteins
was impaired for formation of syncytia in vitro, while dis- Maeda, 1969), the molecular basis for the difference in
morphology has not been determined.ruption of the ORF9A gene alone had only a modest
effect. VZV is highly cell associated in vitro and little, if While we did not see a marked difference in the growth
of the VZV dUTPase stop codon mutant in vitro, the viralany, infectious virus is released into the supernatant
(Weller 1953). Infected cells fuse to form syncytia re- protein may be important for growth of the virus in vivo.
HSV-1 dUTPase mutants are more than 10-fold less neu-sulting in transfer of virus directly to the adjacent cells.
When VZV-infected melanoma cells are grown at 327, the rovirulent, 1,000-fold less neuroinvasive, and are im-
paired for reactivation from latency when compared withsyncytia enlarge so that eventually the entire monolayer
becomes fused and detaches from the substrate (Harson wild-type virus after footpad inoculation in mice (Pyles
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Jons, A., and Mettenleiter, T. C. (1996). Identification and characteriza-et al., 1992). Future experiments will determine whether
tion of pseudorabies virus dUTPase. J. Virol. 70, 1242–1245.disruption of VZV dUTPase (with or without VZV ORF9A)
Keller, P. M., Davison, A. J., Lowe, R. S., Rieman, M. W., and Ellis, R. W.
reduces neurovirulence of VZV and whether these muta- (1987). Identification and sequence of the gene encoding gpIII, a
tions might improve the safety of the Oka VZV vaccine. major glycoprotein of varicella-zoster virus. Virology 157, 526–533.
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